Evidence map›Paper›PMID 42277328›Full record

ArticleCommunications biology2026

Error unawareness as a driver of cognitive decline in individuals at risk for Alzheimer's disease.

Katia Andrade, François-Xavier Lejeune, Nesma Houmani, Rita Yabouri, Michel Thiebaut de Schotten, Valentina Pacella

Abstract read
In one paragraph

Article in Communications biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Katia AndradeInstitute of Memory and Alzheimer's Disease (IM2A), Department of Neurology, Assistance Publique-Hôpitaux de Paris (AP-HP), Sorbonne University, Pitié-Salpêtrière Hospital, Paris, France. katia.santosandrade@gmail.com.ORCID 0000-0002-2577-1747
François-Xavier LejeuneData Analysis Core (DAC; RRID :SCR_026138), Paris Brain Institute-ICM, Sorbonne University, Inserm U1127, CNRS UMR 7225, Pitié-Salpêtrière Hospital, Paris, France.
Nesma HoumaniSAMOVAR, Télécom SudParis, Institut Polytechnique de Paris, Palaiseau, France.
Rita YabouriSAMOVAR, Télécom SudParis, Institut Polytechnique de Paris, Palaiseau, France.
Michel Thiebaut de SchottenGroupe d'Imagerie Neurofonctionnelle (GIN), Institut des Maladies Neurodégénératives-UMR 5293, CNRS, CEA University of Bordeaux, Bordeaux, France.ORCID 0000-0002-0329-1814
Valentina PacellaGroupe d'Imagerie Neurofonctionnelle (GIN), Institut des Maladies Neurodégénératives-UMR 5293, CNRS, CEA University of Bordeaux, Bordeaux, France.ORCID 0000-0001-6168-9954

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Anosognosia, or unawareness of one's deficits, predicts faster clinical progression in Alzheimer's disease (AD), though its mechanisms remain unclear. We investigated five-year trajectories of response awareness and error-monitoring efficiency using second-order judgments from an annual word recognition memory task in cognitively unimpaired individuals at risk for AD from the INSIGHT-preAD cohort. Participants were divided into three groups according to amyloid status at baseline (positive, A + ; negative, A-) and clinical progression (controls, CTRL A+ or A-; and progressors, PROG). Task accuracy declined in PROG, while CTRL A+ showed continued learning, and CTRL A- remained accurate. Inefficient error-monitoring predicted subsequent performance decline in the PROG, with a strong interaction between accuracy and error-monitoring already at baseline. This effect was primarily driven by error unawareness. These findings provide first evidence that error unawareness - a core feature of anosognosia - may foster cognitive decline through the disruption of error-feedback learning mechanisms, potentially accelerating AD progression.

Indexed as

AgnosiaAlzheimer DiseaseAwarenessCognitive DysfunctionAgedDisease ProgressionFemaleHumansMaleNeuropsychological Tests

Identifiers

PMID42277328
PMCPMC13601510

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.